The phrase "as a potential activating" is not correct in standard written English.
It may be intended to describe something that could serve as an activation mechanism or trigger, but it lacks clarity and completeness.
Example: "The new software update is being considered as a potential activating factor for improved system performance."
Alternatives: "as a possible trigger" or "as a potential catalyst".
For this programmed cell death by excess lipid deposition in NASH, a lot of reports have expressed c-Jun NH2terminal kinase (JNK) as a potential modulator activating apoptotic effectors such as p-53-up-regulated mediator of apoptosis (PUMA), Bax, Caspase-3 and −9.
Using Motifscan we identified p90 ribosomal S6 kinase (RSK) as a potential candidate for activating YB-1.
These 10 variations were not considered as potential activating EGFR mutations.
Thymic stromal lymphopoietin (TSLP) has recently been considered as a potential trigger to activate CD1c mDCs in the joints of RA patients.
Approaches to accurately and reproducibly measure multiple nodes in a pathway should allow identification of a tumor's oncogenic pathway addiction as well as highlight potential activated resistance pathways that may result in poor, or limited, response to therapy.
Finally, we explored potential causes of SF-1 over-expression by analysing the copy number of this gene using MLPA, as well as sequencing the promoter region for potential activating mutations.
These data suggest that compartmentalization of Treg cells within secondary lymphoid organs may be governed by antigen recognition and implicate CD69 as a potential marker of recently activated Treg cells recognizing locally expressed antigens.
More importantly, lkb1 mutations have been described in melanoma [32] and based on this information we determined if LKB1 could function as a potential link between an activated RAS pathway and dysfunctional c-Met signaling and play a role in melanoma development and progression.
As discussed above, the emergence of suPAR as a potential factor has certainly activated this research field.
Targeting the p53 Mdm2 interaction with small molecule inhibitors as a potential therapeutic strategy to activate WT p53 has been reviewed earlier (Vassilev, 2007).
In the hydrolysis step, the H300 side chain acted as a potential general base to activate the hydrolytic water molecule for nucleophilic attack on the alkyl enzyme intermediate.
